Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide funding notice was added and the site version updated to v3.4.1, replacing the previous revision v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:17:52.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    No core content changes; minor UI/metadata text updates were made, including Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:08:35.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Footer revision tag updated from Revision: v3.3.3 to Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:18:54.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The Study Locations section was updated: new sites were added across several U.S. states and international locations (e.g., Alabama, Arkansas, California, Colorado, Florida, Missouri, Ohio, Tennessee, Texas, Virginia, Tel Aviv, Chiba, Tokyo, Gyeonggido, Seoul Teugbyeolsi), and several existing sites were removed.
    Difference
    2%
    Check dated 2025-12-23T12:46:40.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    A minor revision update indicates version v3.3.2 was published; no changes to core study content, eligibility, outcomes, or locations are evident in the visible page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:51:05.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.1, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T14:52:08.000Z thumbnail image

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.